The Safety and Efficacy Study of PROTOXIN in Subjects With Moderate to Severe Glabellar Lines
Clinical trial NCT04996810 · COMPLETED
Trial details
- NCT number
- NCT04996810
- Sponsor
- Protox Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-10
- Primary completion
- 2021-04-02
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.